Algert Global LLC Raises Holdings in Alignment Healthcare, Inc. $ALHC

Key Points

• Algert Global LLC increased its holdings in Alignment Healthcare by 37.1%, now owning approximately 238,492 shares valued at $4.44 million.
• Alignment Healthcare reported a revenue increase of 49% year-over-year with earnings per share of $0.07, surpassing analyst estimates.
• Recent analyst ratings for Alignment Healthcare show mixed signals, with some upgrading the stock to a "strong-buy" while others downgraded it to "hold," reflecting a consensus rating of "Moderate Buy."

Algert Global LLC boosted its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 37.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 238,492 shares of the company's stock after buying an additional 64,480 shares during the period. Algert Global LLC owned approximately 0.12% of Alignment Healthcare worth $4,441,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Teacher Retirement System of Texas lifted its stake in shares of Alignment Healthcare by 109.1% in the 1st quarter. Teacher Retirement System of Texas now owns 47,447 shares of the company's stock valued at $883,000 after purchasing an additional 24,755 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Alignment Healthcare by 8.6% during the 4th quarter. Northern Trust Corp now owns 908,964 shares of the company's stock worth $10,226,000 after acquiring an additional 72,063 shares during the last quarter. New York State Common Retirement Fund lifted its stake in shares of Alignment Healthcare by 100.9% during the 1st quarter. New York State Common Retirement Fund now owns 165,642 shares of the company's stock worth $3,084,000 after acquiring an additional 83,187 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of Alignment Healthcare by 905.7% during the 1st quarter. Victory Capital Management Inc. now owns 114,397 shares of the company's stock worth $2,130,000 after acquiring an additional 103,022 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Alignment Healthcare by 3,216.9% during the 1st quarter. GAMMA Investing LLC now owns 23,815 shares of the company's stock worth $443,000 after acquiring an additional 23,097 shares during the last quarter. 86.19% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Joseph S. Konowiecki sold 25,000 shares of the company's stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $16.00, for a total value of $400,000.00. Following the completion of the sale, the director directly owned 1,152,049 shares in the company, valued at $18,432,784. This represents a 2.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Christopher J. Joyce sold 15,491 shares of the company's stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $16.01, for a total value of $248,010.91. Following the completion of the transaction, the insider owned 374,531 shares in the company, valued at $5,996,241.31. This represents a 3.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 599,353 shares of company stock valued at $8,640,501. Insiders own 7.00% of the company's stock.

Analyst Ratings Changes

Several research firms have commented on ALHC. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their price objective for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. UBS Group raised their price objective on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Finally, Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, Alignment Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $18.56.

Alignment Healthcare Stock Up 5.2%

Shares of Alignment Healthcare stock traded up $0.78 during trading on Thursday, reaching $15.80. The company's stock had a trading volume of 3,359,836 shares, compared to its average volume of 3,990,999. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a market cap of $3.13 billion, a price-to-earnings ratio of -56.43 and a beta of 1.16. Alignment Healthcare, Inc. has a 1-year low of $8.24 and a 1-year high of $21.06. The company has a 50-day simple moving average of $13.75 and a two-hundred day simple moving average of $15.30.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company's revenue for the quarter was up 49.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.